In clinical trials, success hinges not just on protocol design and quality data but on choosing the right investigative sites and engaging them effectively. Here are four key reasons why strategic site selection is critical for maximizing value in your clinical trials.
Discover how CRC leveraged our proprietary driving simulator to swiftly complete a next-day effects study in support of a multinational Pharma Company's NDA submission. This case study showcases our ability to navigate complex clinical challenges under tight timelines, finishing 11 days ahead of schedule and exceeding project expectations.
Since 2018, more than 30 drugs with the potential to impair driving ability have been approved without a dedicated driving study, despite clearly meeting the FDA criteria for such studies based on a conservative application of these criteria.